- SVMPharma offers a global approach to Real World Evidence and Patient Experience
- Develops key global insights into specific disease areas in a real life setting
“There is a growing importance of Real World Evidence within healthcare systems globally”
Who would benefit from this?
- Health Economists
- Market access
- Business Intelligence
When would they benefit from this?
- Pre & post launch
- HTA submission
- Competitive brand threat
Real World Evidence Data Generation
- A systematic approach to data collection is required to achieve meaningful outcomes
- Our experts analyse and interpret the data ensuring that your specialist teams have the insights they require
Where do we collect RWE?
SVMPharma conduct RWE within Europe, South East Asia, North and South America directly with:
- Healthcare professionals (specialists and primary care)
- Patients and carers
“SVMPharma’s unique physician-led approach to Real World Evidence leads to tangible outcomes”
Global access to health care professionals and patients
The disease specialities that you need
To find out more about our Global Real World Evidence offerings Email Us or Call +44 (0) 1252 417030
RWE bridging data gaps for a new class of anti-diabetic: one of 13 recent examples of RWE generating outcomes.
Could we really see market authorisation brought forward by 8 years? How Adaptive Pathways with Real World Evidence may change the industry.